Showing 1 - 9 results of 9 for search 'Christoph Wetz', query time: 0.04s Refine Results
  1. 1
    Prognostic Value of the Largest Lesion Size for Progression-Free Survival in Patients with NET Undergoing Salvage PRRT with [<sup>177</sup>Lu]Lu-DOTATOC

    Prognostic Value of the Largest Lesion Size for Progression-Free Survival in Patients with NET Undergoing Salvage PRRT with [<sup>177</sup>Lu]Lu-DOTATOC by Markus Galler, Julian M. M. Rogasch, Kai Huang, Henning Jann, Kristina Plehm, Christoph Wetz, Holger Amthauer

    Published 2022-03-01
    Get full text
    Article
  2. 2
    The Prognostic Value of the De Ritis Ratio for Progression-Free Survival in Patients with NET Undergoing [<sup>177</sup>Lu]Lu-DOTATOC-PRRT: A Retrospective Analysis

    The Prognostic Value of the De Ritis Ratio for Progression-Free Survival in Patients with NET Undergoing [<sup>177</sup>Lu]Lu-DOTATOC-PRRT: A Retrospective Analysis by Tristan Ruhwedel, Julian M. M. Rogasch, Kai Huang, Henning Jann, Imke Schatka, Christian Furth, Holger Amthauer, Christoph Wetz

    Published 2021-02-01
    Get full text
    Article
  3. 3
    Software-assisted dosimetry in peptide receptor radionuclide therapy with 177Lutetium-DOTATATE for various imaging scenarios.

    Software-assisted dosimetry in peptide receptor radionuclide therapy with 177Lutetium-DOTATATE for various imaging scenarios. by Dennis Kupitz, Christoph Wetz, Heiko Wissel, Florian Wedel, Ivayla Apostolova, Thekla Wallbaum, Jens Ricke, Holger Amthauer, Oliver S Grosser

    Published 2017-01-01
    Get full text
    Article
  4. 4
    Added Value of Tomoelastography for Characterization of Pancreatic Neuroendocrine Tumor Aggressiveness Based on Stiffness

    Added Value of Tomoelastography for Characterization of Pancreatic Neuroendocrine Tumor Aggressiveness Based on Stiffness by Emin Gültekin, Christoph Wetz, Jürgen Braun, Dominik Geisel, Christian Furth, Bernd Hamm, Ingolf Sack, Stephan R. Marticorena Garcia

    Published 2021-10-01
    Get full text
    Article
  5. 5
    Asphericity of Somatostatin Receptor Expression in Neuroendocrine Tumors: An Innovative Predictor of Outcome in Everolimus Treatment?

    Asphericity of Somatostatin Receptor Expression in Neuroendocrine Tumors: An Innovative Predictor of Outcome in Everolimus Treatment? by Christoph Wetz, Julian Rogasch, Philipp Genseke, Imke Schatka, Christian Furth, Michael Kreissl, Henning Jann, Marino Venerito, Holger Amthauer

    Published 2020-09-01
    Get full text
    Article
  6. 6
    High-field open versus short-bore magnetic resonance imaging of the spine: a randomized controlled comparison of image quality.

    High-field open versus short-bore magnetic resonance imaging of the spine: a randomized controlled comparison of image quality. by Judith Enders, Matthias Rief, Elke Zimmermann, Patrick Asbach, Gerd Diederichs, Christoph Wetz, Eberhard Siebert, Moritz Wagner, Bernd Hamm, Marc Dewey

    Published 2013-01-01
    Get full text
    Article
  7. 7
    Plasma Markers for Therapy Response Monitoring in Patients with Neuroendocrine Tumors Undergoing Peptide Receptor Radionuclide Therapy

    Plasma Markers for Therapy Response Monitoring in Patients with Neuroendocrine Tumors Undergoing Peptide Receptor Radionuclide Therapy by Christoph Wetz, Tristan Ruhwedel, Imke Schatka, Jane Grabowski, Henning Jann, Giulia Metzger, Markus Galler, Holger Amthauer, Julian M. M. Rogasch

    Published 2023-12-01
    Get full text
    Article
  8. 8
    Same same but different: dopamine transporter SPECT on scanners with CZT vs. NaI detectors

    Same same but different: dopamine transporter SPECT on scanners with CZT vs. NaI detectors by Felix Thiele, Franziska Schau, Julian M. M. Rogasch, Christoph Wetz, Stephanie Bluemel, Winfried Brenner, Holger Amthauer, Catharina Lange, Imke Schatka

    Published 2023-03-01
    Get full text
    Article
  9. 9
    Shortened Tracer Uptake Time in GA-68-DOTATOC-PET of Meningiomas Does Not Impair Diagnostic Accuracy and PET Volume Definition

    Shortened Tracer Uptake Time in GA-68-DOTATOC-PET of Meningiomas Does Not Impair Diagnostic Accuracy and PET Volume Definition by Josefine Graef, Carolin Senger, Christoph Wetz, Alexander D. J. Baur, Anne K. Kluge, Mathias Lukas, Julian M. M. Rogasch, Thula C. Walter-Rittel, David Kohnert, Marcus Makowski, Güliz Acker, Kai Huang, Volker Budach, Holger Amthauer, Imke Schatka, Christian Furth

    Published 2020-12-01
    Get full text
    Article

Search Tools: